10-95058362-G-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000770.3(CYP2C8):​c.792C>G​(p.Ile264Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0453 in 1,613,150 control chromosomes in the GnomAD database, including 1,876 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.035 ( 120 hom., cov: 32)
Exomes 𝑓: 0.046 ( 1756 hom. )

Consequence

CYP2C8
NM_000770.3 missense

Scores

1
5
12

Clinical Significance

Benign criteria provided, single submitter B:3

Conservation

PhyloP100: -0.579

Publications

134 publications found
Variant links:
Genes affected
CYP2C8 (HGNC:2622): (cytochrome P450 family 2 subfamily C member 8) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040852427).
BP6
Variant 10-95058362-G-C is Benign according to our data. Variant chr10-95058362-G-C is described in ClinVar as [Benign]. Clinvar id is 545585.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0507 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2C8NM_000770.3 linkc.792C>G p.Ile264Met missense_variant Exon 5 of 9 ENST00000371270.6 NP_000761.3 P10632-1
CYP2C8NM_001198853.1 linkc.582C>G p.Ile194Met missense_variant Exon 5 of 9 NP_001185782.1 P10632B7Z1F5
CYP2C8NM_001198855.1 linkc.582C>G p.Ile194Met missense_variant Exon 6 of 10 NP_001185784.1 P10632B7Z1F5
CYP2C8NM_001198854.1 linkc.486C>G p.Ile162Met missense_variant Exon 4 of 8 NP_001185783.1 P10632-2B7Z1F5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2C8ENST00000371270.6 linkc.792C>G p.Ile264Met missense_variant Exon 5 of 9 1 NM_000770.3 ENSP00000360317.3 P10632-1

Frequencies

GnomAD3 genomes
AF:
0.0355
AC:
5397
AN:
152042
Hom.:
120
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0119
Gnomad AMI
AF:
0.0504
Gnomad AMR
AF:
0.0312
Gnomad ASJ
AF:
0.0185
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0149
Gnomad FIN
AF:
0.0582
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0521
Gnomad OTH
AF:
0.0368
GnomAD2 exomes
AF:
0.0375
AC:
9410
AN:
251022
AF XY:
0.0374
show subpopulations
Gnomad AFR exome
AF:
0.0111
Gnomad AMR exome
AF:
0.0274
Gnomad ASJ exome
AF:
0.0184
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0568
Gnomad NFE exome
AF:
0.0543
Gnomad OTH exome
AF:
0.0427
GnomAD4 exome
AF:
0.0463
AC:
67688
AN:
1460990
Hom.:
1756
Cov.:
31
AF XY:
0.0456
AC XY:
33142
AN XY:
726798
show subpopulations
African (AFR)
AF:
0.00951
AC:
318
AN:
33438
American (AMR)
AF:
0.0278
AC:
1241
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
0.0201
AC:
524
AN:
26106
East Asian (EAS)
AF:
0.0000757
AC:
3
AN:
39632
South Asian (SAS)
AF:
0.0151
AC:
1306
AN:
86242
European-Finnish (FIN)
AF:
0.0599
AC:
3198
AN:
53396
Middle Eastern (MID)
AF:
0.0187
AC:
107
AN:
5736
European-Non Finnish (NFE)
AF:
0.0526
AC:
58461
AN:
1111450
Other (OTH)
AF:
0.0419
AC:
2530
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
3628
7256
10885
14513
18141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2108
4216
6324
8432
10540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0354
AC:
5394
AN:
152160
Hom.:
120
Cov.:
32
AF XY:
0.0345
AC XY:
2568
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.0119
AC:
494
AN:
41558
American (AMR)
AF:
0.0310
AC:
474
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0185
AC:
64
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.0150
AC:
72
AN:
4816
European-Finnish (FIN)
AF:
0.0582
AC:
615
AN:
10566
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0521
AC:
3545
AN:
67984
Other (OTH)
AF:
0.0365
AC:
77
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
259
518
776
1035
1294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0400
Hom.:
106
Bravo
AF:
0.0332
TwinsUK
AF:
0.0491
AC:
182
ALSPAC
AF:
0.0483
AC:
186
ESP6500AA
AF:
0.0129
AC:
57
ESP6500EA
AF:
0.0548
AC:
471
ExAC
AF:
0.0386
AC:
4687
Asia WGS
AF:
0.00635
AC:
22
AN:
3478
EpiCase
AF:
0.0480
EpiControl
AF:
0.0527

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

CYP2C8-related disorder Benign:1
Feb 07, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

CYP2C8 POLYMORPHISM Benign:1
Jun 20, 2018
OMIM
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
4.8
DANN
Benign
0.96
DEOGEN2
Benign
0.27
.;.;.;T;.
Eigen
Benign
-0.63
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.49
N
LIST_S2
Uncertain
0.86
.;D;D;D;D
MetaRNN
Benign
0.0041
T;T;T;T;T
MetaSVM
Benign
-0.56
T
MutationAssessor
Pathogenic
3.0
.;.;.;M;.
PhyloP100
-0.58
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-2.6
.;D;.;D;.
REVEL
Uncertain
0.36
Sift
Uncertain
0.0030
.;D;.;D;.
Sift4G
Uncertain
0.016
D;D;D;D;D
Polyphen
0.99
.;.;.;D;.
Vest4
0.29
MPC
0.18
ClinPred
0.094
T
GERP RS
-2.8
Varity_R
0.89
gMVP
0.21
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1058930; hg19: chr10-96818119; COSMIC: COSV64877126; API